Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial	Solid Tumors	Active, not recruiting	Phase 3	2026-08-11		NCT02320435

Clinical trials